Cannara Biotech
TSX:LOVE
C$ 1,82
C$-0,02 (-1,09%)
1,82 C$
C$-0,02 (-1,09%)
End-of-day quote: 04/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

C$0,14
Earnings Per Share
C$1,13
Revenue Per Share
43,94%
Gross Margin %
C$0,18 B
Market Cap
C$0,03 B
Long-Term Debt
Earnings Per Share
C$0,14
Revenue Per Share
C$1,13
Gross Margin %
43,94%
Market Cap
C$0,18 B
Long-Term Debt
C$0,03 B

Financials

Year Year 2025 2024 2020
EPS Earnings Per Share C$0,14 C$0,07 C$-0,20
Earnings Earnings C$13,29M C$6,30M C$-14,76M
RPS Revenue Per Share C$1,13 C$0,00 C$0,00
Revenue Revenue C$107,32M C$0,00M C$0,00M
OCF Operating Cash Flow C$20,01M C$0,00M C$0,00M
FCF Free Cash Flow C$0,00M C$0,00M C$0,00M
OM Operating Margin 20,20% 9,35% 0,00%
GM % Gross Margin % 43,94% 36,44% 48,00%
FCFS Free Cash Flow Per Share C$0,15 C$0,04 C$-0,26
LT Debt Long-Term Debt C$28,17M C$38,45M N/A
Sha. Stocks 94,9M 90,02M 73,78M
×